["{\n\"step_by_step_thinking\": \"The study is a randomized, double-blind, placebo-controlled clinical trial. The difference in mean time for resolution of symptoms between the new drug group (6.4 days) and the placebo group (6.4 days) is only 0.3 days, which may not be clinically significant. Although the p-value is 0.04, indicating statistical significance, the magnitude of the difference is small and may not be practically important. Therefore, the findings are likely clinically insignificant but statistically significant.\",\n\"answer_choice\": \"B\"\n}"]